Continuous glucose monitor manufacturer Dexcom has announced plans to raise a total of $1.1bn via issuance of senior convertible notes at an interest rate of 0.375%.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?